跳至主要内容
临床试验/NCT05247281
NCT05247281Enrolling By Invitation不适用

Randomized Controlled Trial Investigating the Use of Next-generation Sequencing in Directing the Antimicrobial Treatment of Periprosthetic Joint Infection

Center for Innovation and Research Organization17 个研究点 分布在 1 个国家目标入组 250 人开始时间: 2022年9月21日最近更新:
适应症

试验速览

阶段
不适用
状态
Enrolling By Invitation
发起方
入组人数
250
试验地点
17
主要终点
Number of participants who have been diagnosed with prosthetic joint infection as assessed by the 2018 International Consensus Definition of prosthetic joint infection

研究概览

简要总结

This multicenter, randomized controlled trial will compare the use of NGS and traditional culture in directing antimicrobial treatment for patients with periprosthetic joint infection.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults (age > 18 years)
  • Undergoing single stage revision or 1st stage resection arthroplasty/spacer placement for PJI (ICM-positive) of the hip or knee
  • Written informed consent

排除标准

  • Ongoing participation in another clinical trial
  • Megaprosthesis

结局指标

主要结局

Number of participants who have been diagnosed with prosthetic joint infection as assessed by the 2018 International Consensus Definition of prosthetic joint infection

时间窗: 90 days from time of surgery

Diagnosis of re-infection following surgery and treatment for prosthetic joint infection

次要结局

  • Number of subjects who have a re-operation as assessed by inpatient hospitalization medical records(one year from time to surgery)

研究者

发起方
Center for Innovation and Research Organization
申办方类型
Network
责任方
Sponsor

研究点 (17)

Loading locations...

相似试验